Entering text into the input field will update the search result below
Search for Symbols, analysts, keywords

Cytokinetics' (NASDAQ:CYTK) shares plunge 11.9% after the company reported that an error in the...

Jul. 08, 2013 8:26 AM ETCytokinetics, Incorporated (CYTK) StockCYTKBy: Yigal Grayeff, SA News Editor1 Comment
Cytokinetics' (NASDAQ:CYTK) shares plunge 11.9% after the company reported that an error in the Phase II trial of its Tirasemtiv treatment for Lou Gehrig's disease caused 58 subjects to incorrectly receive a placebo rather than the drug.

Recommended For You

About CYTK Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CYTK--
Cytokinetics, Incorporated

Trending Analysis

Trending News